Hosted on MSN20h
Wall Street Analysts Predict a 25.59% Upside in BioNTech (BNTX): Here's What You Should Know
BioNTech SE Sponsored ADR (BNTX) closed the last trading session at $112.76, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ...
Bank of America Securities Keeps Their Buy Rating on BioNTech SE (BNTX)
Bank of America Securities analyst Tazeen Ahmad maintained a Buy rating on BioNTech SE (BNTX – Research Report) yesterday and set a price ...
Moderna's mRNA Technology Looks Undervalued Despite Lower Covid Vaccine Demand
Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...
Hosted on MSN7d
Truist Securities Initiates Coverage of BioNTech SE - Depositary Receipt () (BNTX) with Buy Recommendation
Fintel reports that on January 10, 2025, Truist Securities initiated coverage of BioNTech SE - Depositary Receipt () (NasdaqGS:BNTX) with a Buy recommendation. Analyst Price Forecast Suggests 14.22% ...
What’s Behind The Recent Rise In MRNA Stock?
The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.
Finbold | Finance in Bold9d
Here’s why vaccine stocks are surging in 2025
Vaccine stocks received a major and sudden boost on January 7, 2025. Here's why these companies are experiencing tailwinds in ...
Moderna, Novavax and other vaccine names extend gains amid COVID/flu concerns
Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more ...
Future Market Insights10d
Pediatric Vaccine Industry to Reach USD 184,706.7 Million by 2033, Growing at a Remarkable CAGR of 13.1%
The global pediatric vaccine market is set for unprecedented growth, with a valuation of US$ 54,130.1 million in 2023, ...
securities16d
Top 5 Blue Chip Pharmaceutical Companies (January 2025)
The innovation itself was very much invented by BioNTech, which took an actually quite old scientific concept and turned it into an entire technology platform. When the pandemic arrived, it was the ...
Goethe18d
Goethe-Institut USA
The Goethe-Institut USA is Germany's offical cultural center with convenient and effective online German courses and internationally recognized language certificates. As the international market ...
Pharmaceutical Technology19d
DB-1311 by BioNTech for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Likelihood of Approval
DB-1311 is under clinical development by BioNTech and currently in Phase II for Metastatic Castration-Resistant Prostate Cancer (mCRPC). According to GlobalData, Phase II drugs for Metastatic ...
dw21d
COVID: BioNTech to pay $1.2 billion over vaccine royalties
German pharmaceutical company BioNTech has agreed to pay a combined sum of more than $1.2 billion to resolve separate disputes over royalty payments related to its COVID-19 vaccine. https://p.dw ...